Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase
- 21 February 2006
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 534 (1-3) , 63-70
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Effects of novel antipsychotics with mixed D2 antagonist/5-HT1A agonist properties on PCP-induced social interaction deficits in the ratNeuropharmacology, 2005
- Contrasting Contribution of 5-Hydroxytryptamine 1A Receptor Activation to Neurochemical Profile of Novel Antipsychotics: Frontocortical Dopamine and Hippocampal Serotonin Release in Rat BrainThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Clozapine and the mitogen-activated protein kinase signal transduction pathway: Implications for antipsychotic actionsBiological Psychiatry, 2005
- Co-expression and In Vivo Interaction of Serotonin1A and Serotonin2A Receptors in Pyramidal Neurons of Prefrontal CortexCerebral Cortex, 2004
- Sarizotan, a serotonin 5-HT 1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profileJournal of Neural Transmission, 2004
- Is there a role for 5-HT1A agonists in the treatment of depression?Biological Psychiatry, 2003
- Endogenous RGS proteins facilitate dopamine D2S receptor coupling to Gαo proteins and Ca2+ responses in CHO‐K1 cellsFEBS Letters, 2002
- The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?Journal of Psychopharmacology, 2001
- Agonist Stimulation of the Serotonin1A Receptor Causes Suppression of Anoxia‐Induced Apoptosis via Mitogen‐Activated Protein Kinase in Neuronal HN2‐5 CellsJournal of Neurochemistry, 1999
- Pharmacological actions of the atypical antipsychotic drug clozapine: A reviewSynapse, 1996